Hugh C Hendrie1, Jill Murrell2, Olusegun Baiyewu3, Kathleen A Lane4, Christianna Purnell5, Adesola Ogunniyi6, Frederick W Unverzagt7, Kathleen Hall7, Christopher M Callahan1, Andrew J Saykin8, Oye Gureje3, Ann Hake9, Tatiana Foroud10, Sujuan Gao4. 1. Indiana University Center for Aging Research, Indianapolis, Indiana, USA. 2. Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA. 3. Department of Psychiatry, College of Medicine, University of Ibadan, Ibadan, Nigeria. 4. Department of Biostatistics, Indiana University School of Medicine, Indianapolis, Indiana, USA. 5. Regenstrief Institute, Inc., Indianapolis, Indiana, USA. 6. Department of Medicine, College of Medicine, University of Ibadan, Ibadan, Nigeria. 7. Department of Psychiatry, Indiana University School of Medicine, Indianapolis, Indiana, USA. 8. Department of Radiology and Imaging Services, Indiana University School of Medicine, Indianapolis, Indiana, USA. 9. Department of Neurology, Indiana University School of Medicine, Indianapolis, Indiana, USA. 10. Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Abstract
BACKGROUND: There is little information on the association of the APOEe4 allele and AD risk in African populations. In previous analyses from the Indianapolis-Ibadan dementia project, we have reported that APOE ε4 increased the risk for Alzheimer's disease (AD) in African Americans but not in Yoruba. This study represents a replication of this earlier work using enriched cohorts and extending the analysis to include cognitive decline. METHODS: In this longitudinal study of two community dwelling cohorts of elderly Yoruba and African Americans, APOE genotyping was conducted from blood samples taken on or before 2001 (1,871 African Americans & 2,200 Yoruba). Mean follow up time was 8.5 years for African Americans and 8.8 years for Yoruba. The effects of heterozygosity or homozygosity of ε4 and of the possession of e4 on time to incident AD and on cognitive decline were determined using Cox's proportional hazards regression and mixed effects models. RESULTS: After adjusting for covariates, one or two copies of the APOE ε4 allele were significant risk factors for incident AD (p < 0.0001) and cognitive decline in the African-American population (p < 0001). In the Yoruba, only homozygosity for APOE ε4 was a significant risk factor for AD (p = 0.0002) but not for cognitive decline (p = 0.2346), however, possession of an e4 allele was significant for both incident AD (p = 0.0489) and cognitive decline (p = 0.0425). CONCLUSIONS: In this large longitudinal comparative study, APOE ε4 had a significant, but weaker, effect on incident AD and on cognitive decline in Yoruba than in African Americans. The reasons for these differences remain unclear.
BACKGROUND: There is little information on the association of the APOEe4 allele and AD risk in African populations. In previous analyses from the Indianapolis-Ibadan dementia project, we have reported that APOE ε4 increased the risk for Alzheimer's disease (AD) in African Americans but not in Yoruba. This study represents a replication of this earlier work using enriched cohorts and extending the analysis to include cognitive decline. METHODS: In this longitudinal study of two community dwelling cohorts of elderly Yoruba and African Americans, APOE genotyping was conducted from blood samples taken on or before 2001 (1,871 African Americans & 2,200 Yoruba). Mean follow up time was 8.5 years for African Americans and 8.8 years for Yoruba. The effects of heterozygosity or homozygosity of ε4 and of the possession of e4 on time to incident AD and on cognitive decline were determined using Cox's proportional hazards regression and mixed effects models. RESULTS: After adjusting for covariates, one or two copies of the APOE ε4 allele were significant risk factors for incident AD (p < 0.0001) and cognitive decline in the African-American population (p < 0001). In the Yoruba, only homozygosity for APOE ε4 was a significant risk factor for AD (p = 0.0002) but not for cognitive decline (p = 0.2346), however, possession of an e4 allele was significant for both incident AD (p = 0.0489) and cognitive decline (p = 0.0425). CONCLUSIONS: In this large longitudinal comparative study, APOE ε4 had a significant, but weaker, effect on incident AD and on cognitive decline in Yoruba than in African Americans. The reasons for these differences remain unclear.
Authors: Jacob A Tennessen; Abigail W Bigham; Timothy D O'Connor; Wenqing Fu; Eimear E Kenny; Simon Gravel; Sean McGee; Ron Do; Xiaoming Liu; Goo Jun; Hyun Min Kang; Daniel Jordan; Suzanne M Leal; Stacey Gabriel; Mark J Rieder; Goncalo Abecasis; David Altshuler; Deborah A Nickerson; Eric Boerwinkle; Shamil Sunyaev; Carlos D Bustamante; Michael J Bamshad; Joshua M Akey Journal: Science Date: 2012-05-17 Impact factor: 47.728
Authors: Yi-Fang Chuang; Kathleen M Hayden; Maria C Norton; Joann Tschanz; John C S Breitner; Kathleen A Welsh-Bohmer; Peter P Zandi Journal: Dement Geriatr Cogn Disord Date: 2010-04-06 Impact factor: 2.959
Authors: Sarah A Tishkoff; Floyd A Reed; Françoise R Friedlaender; Christopher Ehret; Alessia Ranciaro; Alain Froment; Jibril B Hirbo; Agnes A Awomoyi; Jean-Marie Bodo; Ogobara Doumbo; Muntaser Ibrahim; Abdalla T Juma; Maritha J Kotze; Godfrey Lema; Jason H Moore; Holly Mortensen; Thomas B Nyambo; Sabah A Omar; Kweli Powell; Gideon S Pretorius; Michael W Smith; Mahamadou A Thera; Charles Wambebe; James L Weber; Scott M Williams Journal: Science Date: 2009-04-30 Impact factor: 47.728
Authors: Jacob F Degner; Athma A Pai; Roger Pique-Regi; Jean-Baptiste Veyrieras; Daniel J Gaffney; Joseph K Pickrell; Sherryl De Leon; Katelyn Michelini; Noah Lewellen; Gregory E Crawford; Matthew Stephens; Yoav Gilad; Jonathan K Pritchard Journal: Nature Date: 2012-02-05 Impact factor: 49.962
Authors: Jordana T Bell; Athma A Pai; Joseph K Pickrell; Daniel J Gaffney; Roger Pique-Regi; Jacob F Degner; Yoav Gilad; Jonathan K Pritchard Journal: Genome Biol Date: 2011-01-20 Impact factor: 13.583
Authors: Christiane Reitz; Gyungah Jun; Adam Naj; Ruchita Rajbhandary; Badri Narayan Vardarajan; Li-San Wang; Otto Valladares; Chiao-Feng Lin; Eric B Larson; Neill R Graff-Radford; Denis Evans; Philip L De Jager; Paul K Crane; Joseph D Buxbaum; Jill R Murrell; Towfique Raj; Nilufer Ertekin-Taner; Mark Logue; Clinton T Baldwin; Robert C Green; Lisa L Barnes; Laura B Cantwell; M Daniele Fallin; Rodney C P Go; Patrick Griffith; Thomas O Obisesan; Jennifer J Manly; Kathryn L Lunetta; M Ilyas Kamboh; Oscar L Lopez; David A Bennett; Hugh Hendrie; Kathleen S Hall; Alison M Goate; Goldie S Byrd; Walter A Kukull; Tatiana M Foroud; Jonathan L Haines; Lindsay A Farrer; Margaret A Pericak-Vance; Gerard D Schellenberg; Richard Mayeux Journal: JAMA Date: 2013-04-10 Impact factor: 56.272
Authors: Sungeun Kim; Kwangsik Nho; Vijay K Ramanan; Dongbing Lai; Tatiana M Foroud; Katie Lane; Jill R Murrell; Sujuan Gao; Kathleen S Hall; Frederick W Unverzagt; Olusegun Baiyewu; Adesola Ogunniyi; Oye Gureje; Mitchel A Kling; P Murali Doraiswamy; Rima Kaddurah-Daouk; Hugh C Hendrie; Andrew J Saykin Journal: J Alzheimers Dis Date: 2016 Impact factor: 4.472
Authors: Andrea Denny; Marissa Streitz; Kristin Stock; Joyce E Balls-Berry; Lisa L Barnes; Goldie S Byrd; Raina Croff; Sujuan Gao; Crystal M Glover; Hugh C Hendrie; William T Hu; Jennifer J Manly; Krista L Moulder; Susan Stark; Stephen B Thomas; Rachel Whitmer; Roger Wong; John C Morris; Jennifer H Lingler Journal: Alzheimers Dement Date: 2020-08-17 Impact factor: 21.566
Authors: Vivian P Lara; Paulo Caramelli; Antônio L Teixeira; Maira T Barbosa; Karoline C Carmona; Henrique C Guimarães; Maria G Carvalho; Ana P Fernandes; Karina B Gomes Journal: J Clin Lab Anal Date: 2015-08-24 Impact factor: 2.352
Authors: Aziz M Mezlini; Colin Magdamo; Emily Merrill; Lori B Chibnik; Deborah L Blacker; Bradley T Hyman; Sudeshna Das Journal: J Alzheimers Dis Date: 2020 Impact factor: 4.472
Authors: Timothy J Hohman; Jessica N Cooke-Bailey; Christiane Reitz; Gyungah Jun; Adam Naj; Gary W Beecham; Zhi Liu; Regina M Carney; Jeffrey M Vance; Michael L Cuccaro; Ruchita Rajbhandary; Badri Narayan Vardarajan; Li-San Wang; Otto Valladares; Chiao-Feng Lin; Eric B Larson; Neill R Graff-Radford; Denis Evans; Philip L De Jager; Paul K Crane; Joseph D Buxbaum; Jill R Murrell; Towfique Raj; Nilufer Ertekin-Taner; Mark W Logue; Clinton T Baldwin; Robert C Green; Lisa L Barnes; Laura B Cantwell; M Daniele Fallin; Rodney C P Go; Patrick Griffith; Thomas O Obisesan; Jennifer J Manly; Kathryn L Lunetta; M Ilyas Kamboh; Oscar L Lopez; David A Bennett; John Hardy; Hugh C Hendrie; Kathleen S Hall; Alison M Goate; Rosalyn Lang; Goldie S Byrd; Walter A Kukull; Tatiana M Foroud; Lindsay A Farrer; Eden R Martin; Margaret A Pericak-Vance; Gerard D Schellenberg; Richard Mayeux; Jonathan L Haines; Tricia A Thornton-Wells Journal: Alzheimers Dement Date: 2015-06-16 Impact factor: 21.566
Authors: Nemin Chen; Christina Caruso; Alvaro Alonso; Vimal K Derebail; Abhijit V Kshirsagar; A Richey Sharrett; Nigel S Key; Rebecca F Gottesman; Megan L Grove; Jan Bressler; Eric Boerwinkle; B Gwen Windham; Thomas H Mosley; Hyacinth I Hyacinth Journal: eNeurologicalSci Date: 2019-07-22
Authors: Sharmin Hossain; Michele K Evans; Alan B Zonderman; May A Beydoun; Jordan Weiss; Marie F Kuczmarski Journal: Br J Nutr Date: 2020-04-06 Impact factor: 3.718
Authors: Jaime Perales-Puchalt; Kathryn Gauthreaux; Ashley Shaw; Jerrihlyn L McGee; Merilee A Teylan; Kwun C G Chan; Katya Rascovsky; Walter A Kukull; Eric D Vidoni Journal: Int Psychogeriatr Date: 2020-01-17 Impact factor: 3.878